For Patients in Need

The Science of CBD

Enveric Biosciences seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies.

Development Programs

Enveric Biosciences has a robust pipeline with multiple data points expected in 2021 for radiodermatitis, glioblastoma and chemotherapy-induced neuropathy.